VitaSpring Biomedical Co. Ltd. (VSBC) income statement
VSBCOTCServices-Commercial Physical & Biological ResearchFiscal year ends January 31
Số liệu tài chính tới Q2 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 17, 2026Score 4/30
$0.03+0.00 (0.00%)
Close on Oct 19, 2026Market cap $6.58MP/E –Yield –
VitaSpring Biomedical Co. Ltd. income statement
Ratios
Latest available, balances at Jul 31, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2026
- 9.8%
Financial strength
- Current ratio
- 0.01
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 0.6%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?